No spam - just the good stuff

Subscribe to our newsletter
Hidden
  • News
  • Investor Portal
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

InvestmentInvestor Portal

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
News > Longevity 2020How can BioViva address the here and now?

How can BioViva address the here and now?

Author: Phil Newman  |  Published on: May 1, 2020  |  Last updated: May 10, 2022

Liz Parrish

CEO, BioViva Sciences

How can BioViva address the here and now?


 

Share this article:

Editor's choice

‘Data-driven health is going to be the biggest revolution in the history of medicine’

Leveraging the past to illuminate longevity for the future

‘It’s always too early to say something’s impossible’

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

Calling all longevity clinicians: your voice matters!

Combining AI and MRI to improve human longevity

Popular articles

Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more

Stay cool: the longevity tech that “shows insane promise”

Does SIRT6 hold the key to human longevity?

Tally up! Consumer longevity company lands $10m

Longevity: ‘money-spinning cult’ or the future of health?

Zuzalu: a pop-up city with longevity at its heart

More like this

‘I want medical tourism to be open to everyone, forever’

Features

‘We are information machines – and it’s time to renew the code.’

Investment

‘It’s always too early to say something’s impossible’

Videos

‘We’re at the longevity inflection point – and the explosion is coming.’

Features

Longevity to a sirtuin extent

Videos

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

Features

Longevity: This time it’s personal

Supplements

SIRT6: The protein that talks the talk and walks the walk

Videos

Navigate the emerging field of longevity

Economy

It’s a brave new world – but longevity needs to stay in the realm of the credible

Economy

Unlocking longevity potential: GlycanAge’s approach to longevity, healthspan and menopause

Diagnostics

A strong patent portfolio delivers a competitive edge in the longevity space

Investment

Juvenescence: Think aging up, rather than disease down

Features

Combilytics: Taking a combined approach to senescence

Supplements

Investing in Longevity 101

Economy

Getting comfortable with senotherapeutics

Biotech

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS
The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.